Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusIntensive glucose control versus conventional glucose control for type 1 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusIntensive glucose control versus conventional glucose control for type 1 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusPolypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 DiabetesUpdate on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a reviewMultiple functional ingredient approach in formulating dietary supplement for management of diabetes: a review.Increased inducibility of ventricular tachycardia and decreased heart rate variability in a mouse model for type 1 diabetes: effect of pravastatinReal-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis.Standards of medical care in diabetes--2010.Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetesChanging the treatment paradigm for type 2 diabetes.Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.Implications of postprandial glucose and weight control in people with type 2 diabetes: understanding and implementing the International Diabetes Federation guidelinesThe relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11).Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA.Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials.Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort studyDiabetes: glycaemic control in type 1Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry.Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin.Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.Investigation of mean platelet volume in patients with type 2 diabetes mellitus and in subjects with impaired fasting glucose: a cost-effective tool in primary health care?Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Standards of medical care in diabetes--2011.Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.Increase in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injuryThe effects of pioglitazone in reducing atherosclerosis progression and neointima volume in type 2 diabetic patients: prospective randomized study with volumetric intravascular ultrasonography analysis.Glycated hemoglobin independently predicts stroke recurrence within one year after acute first-ever non-cardioembolic strokes onset in A Chinese cohort study.Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational studyChronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trGlycemia and cardiovascular risk: challenging evidence based medicine.Antioxidant, antidiabetic and hypolipidemic effects of Tulbaghia violacea Harv. (wild garlic) rhizome methanolic extract in a diabetic rat model.Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes.Assessing Diabetes Self-Management with the Diabetes Self-Management Questionnaire (DSMQ) Can Help Analyse Behavioural Problems Related to Reduced Glycaemic Control
P2860
Q22241786-4293B640-2222-46A9-B7A0-3EE28433E9F1Q24186667-8472BD0C-EF28-446F-91AA-54A000CAA605Q24200376-29A4226E-4413-4C58-8457-F66CDEE9062AQ24202505-F4CD6BF2-67DE-4FBA-AB01-B5E397422218Q24234960-645B9093-1368-4447-9D86-AFD0801A7F34Q24236456-EA209CD3-8487-4705-AC34-55B0449C1D9CQ24241529-16BB8DC7-CF8D-4CED-A57D-25BFECC8D131Q26767283-88843FEE-23D6-425D-8A8A-F06E0CEEAB68Q27687851-FEC0FA40-5542-490B-90D9-445681CC084BQ28070256-2C22C997-6771-4F3C-A9E6-658F579AE1B6Q30358713-D4CEB858-080F-4D17-8B2B-D83EF8779CA5Q30562309-0C81D816-5544-427D-930A-A381B0A2261AQ31149131-06F74105-9DAF-42BB-AA11-5F7F31DDB4D1Q33554238-C804926C-0DD9-4858-B81E-F2459C781270Q33585657-0C35F928-967F-45DC-AC58-E07FC48101B1Q33609799-674D2F55-D05C-4D8D-9A77-D3AD3DCB3F87Q33610676-96579F19-BEB2-4457-B464-94FC4B3777CCQ33610830-9FA46AA1-B595-40C2-A35F-3F02DBAAA392Q33610842-450294DE-0EAB-4B8D-A8E5-B2D174E633B1Q33689318-B05A4AD6-A5F4-4EE2-98C3-881974B382A1Q33700904-FEBF2119-70F9-45CB-AFFF-DF0A96262E32Q33802823-A122C317-6F72-4784-B9FE-EDC22F41A0C5Q33875464-C7888BA7-80E3-4D3F-BD7B-A1A93219663FQ33891703-2AFDD261-AE3A-4154-A618-C4FBD7693D95Q33945039-C3C1BB10-6FB8-45AC-8AD6-07953C20E0C6Q33960995-35F92F91-7C9B-468C-A3FE-B452CA5FDE02Q34071861-D0069D17-29C0-46DA-B914-C0E315C2CB3CQ34167250-E6974E70-47C2-4A81-8839-014BDFA180F0Q34219439-B006BCE3-2B6A-4AA5-94CF-7492A4E6CD16Q34425055-D3999B79-B6FA-4618-93F9-064F4DA933FEQ34449270-E55652C1-2849-4F66-8E96-196EE541810CQ34459819-2B11DD76-AC48-4952-8681-097BA20E68EFQ34512533-904420E3-6BFB-4B45-9CFE-C4F8FCD2AD51Q35044001-246ACC0A-01D1-4EAA-88D8-CAA8935BEDC5Q35069696-404D618A-50D5-44D6-96DA-1F171D814A42Q35688224-2AF302C6-8FA4-4774-B8DD-ABD4916D986CQ35835351-81A5A172-6FFB-4F7C-AD73-0F29F58E61A9Q35844143-7934D348-93B8-491D-B8EF-D19B9542F3E8Q35898351-BA43E979-8D13-4FDD-8E86-8FF574BE5467Q35944772-FD8CE9B0-5428-4E05-B438-5369233A5678
P2860
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Glycemic control and macrovasc ...... analysis of randomized trials.
@ast
Glycemic control and macrovasc ...... analysis of randomized trials.
@en
type
label
Glycemic control and macrovasc ...... analysis of randomized trials.
@ast
Glycemic control and macrovasc ...... analysis of randomized trials.
@en
prefLabel
Glycemic control and macrovasc ...... analysis of randomized trials.
@ast
Glycemic control and macrovasc ...... analysis of randomized trials.
@en
P2093
P1476
Glycemic control and macrovasc ...... analysis of randomized trials.
@en
P2093
Carole A Cull
Christoph Stettler
Peter Diem
Rury R Holman
Sabin Allemann
Stephan Krähenbühl
P356
10.1016/J.AHJ.2005.09.015
P407
P577
2006-07-01T00:00:00Z